2014
DOI: 10.3390/ijms15033989
|View full text |Cite
|
Sign up to set email alerts
|

Increased Circulatory Asymmetric Dimethylarginine and Multiple Organ Failure: Bile Duct Ligation in Rat as a Model

Abstract: Bile duct ligation (BDL)-treated rats exhibit cholestasis, increased systemic oxidative stress, and liver fibrosis, which ultimately lead to liver cirrhosis. Asymmetric dimethylarginine (ADMA) is a competitive inhibitor of nitric oxide synthase that can decrease the synthesis of nitric oxide. BDL rats have higher plasma and hepatic ADMA levels, which may be due to increased hepatic protein arginine methyltransferase-1 and decreased dimethylarginine dimethylaminohydrolase expression. BDL rats also exhibit renal… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
19
0
2

Year Published

2015
2015
2023
2023

Publication Types

Select...
8

Relationship

0
8

Authors

Journals

citations
Cited by 23 publications
(21 citation statements)
references
References 125 publications
(164 reference statements)
0
19
0
2
Order By: Relevance
“…ADMA also led to secretion of various factors and tissue damage by causing endothelial dysfunction. Increased levels of ADMA that inhibit NO synthesis were found to be associated with endothelial dysfunction, vasoconstriction, peripheral artery disease, coronary artery diseases, preeclampsia, hypertension, stroke, heart failure, chronic kidney failure, portal hypertension observed in the clinical picture of cirrhosis, diabetes mellitus, and insulin resistance in the patients with essential hypertension (Alacam et al, 2011;Sheen et al, 2014). It is known that ADMA increases in hepatic diseases; however, it is still controversial whether increased ADMA level is the reason for or the result of hepatic deterioration.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…ADMA also led to secretion of various factors and tissue damage by causing endothelial dysfunction. Increased levels of ADMA that inhibit NO synthesis were found to be associated with endothelial dysfunction, vasoconstriction, peripheral artery disease, coronary artery diseases, preeclampsia, hypertension, stroke, heart failure, chronic kidney failure, portal hypertension observed in the clinical picture of cirrhosis, diabetes mellitus, and insulin resistance in the patients with essential hypertension (Alacam et al, 2011;Sheen et al, 2014). It is known that ADMA increases in hepatic diseases; however, it is still controversial whether increased ADMA level is the reason for or the result of hepatic deterioration.…”
Section: Discussionmentioning
confidence: 99%
“…It is found in the literature that the ADMA/DDAH/NO pathway is considered responsible in the pathophysiology of many diseases (Sheen et al, 2014). This pathway is also blamed for the pathophysiology of hepatic diseases.…”
Section: Introductionmentioning
confidence: 99%
“…In addition, in the BDL rat model, ADMA level significantly raises in the peripheral blood, whereas the concentration of l -arginine decreases [51]. Of note in this context, the PRMT-1 protein content was elevated in the liver of BDL rats [52, 53], but reduced in BDL rat brain [46].…”
Section: Adma In Liver Dysfunction: Implications To the Hementioning
confidence: 99%
“…Вступ. Від стану жовчних шляхів залежить здоров'я основної «фабрики» організмупечінки [1,2]. Пошкодження епітелію слизової оболонки жовчних проток, зумовлене аутоімунним дисбалансом, вірусною чи бактеріальною інфекцією, токсичними речовинами чи аномаліями розвитку, призводить до важких структурних змін печінки, обумовлюючи високу смертність [3].…”
unclassified